Skip to main content
. 2014 Oct 17;17(5):678–684. doi: 10.1093/neuonc/nou298

Fig. 2.

Fig. 2.

Kaplan–Meier curves showing differences in overall survival by low/high EGFRvIII antibody level (dichotomized at the median). Log-rank test shows the association between higher EGFRvIII antibody level and longer survival (P = .004).